JVC Investment Partners logo

JVC Investment Partners

North America, Illinois, United States, Northbrook

Description

JVC is a private investment firm that partners with owners and managers of middle market companie.

Investor Profile

JVC Investment Partners has made 5 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (40%)
  • Series Unknown (40%)
  • Series B (20%)

Country Focus

  • United States (40%)
  • Israel (40%)
  • The Netherlands (20%)

Industry Focus

  • Biotechnology
  • Life Science
  • Health Care
  • Pharmaceutical
  • Medical
  • Medical Device
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does JVC Investment Partners frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Johnson & Johnson Innovation – JJDC
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 3
RM Global Partners
North America, New York, United States, New York
Co-Investments: 1
HH
North America, California, United States, San Francisco
Co-Investments: 1
Bukwang Pharmaceutical Co
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 2
Pitango VC
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 2
Takeda Ventures
North America, California, United States, San Diego
Co-Investments: 2

Which angels does JVC Investment Partners often collaborate with?

PT
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by JVC Investment Partners?

Magenta Medical

Kadima, HaMerkaz, Israel

Magenta Medical is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.

Health CareMedicalMedical Device
Series UnknownJul 23, 2024
Amount Raised: $105,000,000
New Amsterdam Pharma

Naarden, Noord-Holland, The Netherlands

New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.

BiotechnologyLife SciencePharmaceutical
Series AJan 14, 2021
Amount Raised: $194,412,819
ImmPACT Bio

Camarillo, California, United States

ImmPACT Bio USA is developing novel cell therapies for treating cancer.

BiotechnologyLife Science
Series AAug 18, 2020
Amount Raised: $18,000,000
Arcellx

Gaithersburg, Maryland, United States

Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.

BiopharmaBiotechnologyHealth CareLife SciencePharmaceutical
Series BOct 3, 2019
Amount Raised: $85,000,000
Magenta Medical

Kadima, HaMerkaz, Israel

Magenta Medical is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.

Health CareMedicalMedical Device
Series UnknownJul 29, 2019